Search

Your search keyword '"Ylösmäki, Erkko"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Ylösmäki, Erkko" Remove constraint Author: "Ylösmäki, Erkko"
119 results on '"Ylösmäki, Erkko"'

Search Results

1. PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines

6. List of contributors

7. Artificially cloaked viral nanovaccine for cancer immunotherapy

8. Data from Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

9. Supplementary Tables and Figures from Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

10. Supplementary Data File S1 from Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

11. Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses

12. Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

13. Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

14. A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

16. Author response: A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

17. PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

18. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

20. Abstract 1488: Viral molecular mimicry influences the antitumor immune response in murine and human melanoma

21. Abstract 1867: Characterization in patient derived tumor organoids of novel oncolytic adenoviruses expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitors

22. Abstract 1897: PeptiCHIP: A novel microfluidic-based chip platform for tumor antigen landscape identification

24. A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

26. Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

27. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

28. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

29. PeptiCHIP: a novel microfluidic-based chip platform for tumour antigen landscape identification

30. GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

31. GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

32. Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

34. Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

35. Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy

38. Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma.

39. Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

40. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

42. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

43. Abstract A034: Boosting the efficacy of PD-L1 blockade with oncolytic vaccine for improved antitumor responses in melanoma

45. Rational engineering of microRNA-regulated viruses for cancer gene therapy

46. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma

48. Melanocarpus albomyces –lakkaasin C-terminuksen mutagenisointi:Pro gradu

49. MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver

50. Rational engineering of microRNA-regulated viruses for cancer gene therapy

Catalog

Books, media, physical & digital resources